Dianthus Therapeutics’ (DNTH) Outperform Rating Reiterated at Wedbush
Wedbush reissued their outperform rating on shares of Dianthus Therapeutics (NASDAQ:DNTH – Free Report) in a research note issued to investors on Wednesday morning,Benzinga reports. The firm currently has a $36.00 target price on the stock. Wedbush also issued estimates for Dianthus Therapeutics’ Q1 2025 earnings at ($0.74) EPS, Q2 2025 earnings at ($0.79) EPS, […]
Wedbush reissued their outperform rating on shares of Dianthus Therapeutics (NASDAQ:DNTH – Free Report) in a research note issued to investors on Wednesday morning,Benzinga reports. The firm currently has a $36.00 target price on the stock. Wedbush also issued estimates for Dianthus Therapeutics’ Q1 2025 earnings at ($0.74) EPS, Q2 2025 earnings at ($0.79) EPS, […]
